通过下一代测序对一个新型HLA-B*51:01:01:125等位基因的表征
Mirzokhid Rakhmanov1, Martin Bernheiden1, Murielle Verboom2
1Institute for Transfusion Medicine and Gene Therapy, Medical Center - University of Freiburg, Medical Faculty - Universityof Freiburg, University of Freiburg, Freiburg, Germany.
HLA
|March 12, 2025
概括
在内子1中的单个核酸替代区分了两个人类白细胞抗原-B基因,HLA-B*51:01:01:125和HLA-B*51:01:01:61. 这种遗传变异会影响HLA等位基因的识别和表征.
科学领域:
- 免疫遗传学 免疫遗传学
- 分子生物学分子生物学
背景情况:
- 人类白细胞抗原 (HLA) 基因具有高度多态性.
- 准确的HLA等位基因命名对于临床和研究应用至关重要.
研究的目的:
- 为了确定两个密切相关的HLA-B等位基因之间的特定遗传差异:HLA-B*51:01:01:125和HLA-B*51:01:01:61.
主要方法:
- 对已识别的HLA-B等位基因组序列进行比较分析.
- 专注于内部区域内的核酸变异.
主要成果:
- 鉴定出唯一的差异是在内突1中的基因组位置199的单个核酸替代.
- 这种变异使HLA-B*51:01:01:125与HLA-B*51:01:01:61区别开来.
结论:
- 这项研究精确地定义了区分这两种HLA-B等位基因的遗传基础.
- 突出了HLA等位基因分化中的内基变异的重要性.
关键词:
哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈HLA-B*51:01:01:125 这是一个很好的方法.国家储备系统 (NGS)一个新型的等位基因拼接地点 拼接地点更多相关视频
11:22Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
27.7K
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
11.7K
相关概念视频
03:00Next-generation Sequencing
86.7K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
86.7K
01:11Genome-wide Association Studies-GWAS
12.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.3K